After attending this presentation, participants will be able to:

• Summarize the federal regulation governing telehealth prescribing of controlled substance and develop a plan for prospective upcoming changes to this regulatory framework.
• Explain the impact of the shortage of psychostimulant medications on the treatment of attention deficit hyperactivity disorder and other psychiatric conditions. 
• Counsel patients about the risks of nonmedical prescription drug use